Spironolactone: An Anti-Androgenic and Anti-Hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
July 2020
in “
Frontiers in Medicine
”
New to Spironolactone? There is a guide in the encyclopedia. Read the guide →
Studysummary Spironolactone might help protect against severe lung problems in COVID-19 patients.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer